Samuel Zachary Goldhaber
Samuel Zachary Goldhaber publishes mostly in Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes and Acute Myocardial Infarction Research.
- World rank
- #43,713 of 7,710,434 ranked researchers
- Rank in United States
- #16,802 of 1,627,098
- Works
- 1,085
- Citations
- 94k
- Citations per work
- 86.7
What does Samuel Zachary Goldhaber research?
Samuel Zachary Goldhaber's work is mostly in Medicine (77%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences83977.3%
- Medicine83977.3%
- Everything else24622.7%
- 1Internal Medicine27% of their works
- 2Cardiology and Cardiovascular Medicine27% of their works
- 3Surgery9% of their works
- 4Epidemiology5% of their works
- 5Hematology5% of their works
- 6Pulmonary and Respiratory Medicine4% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Blood Coagulation and Thrombosis Mechanisms
- Acute Ischemic Stroke Management
- Diagnosis and Treatment of Venous Diseases
- Central Venous Catheters and Hemodialysis
- Heparin-Induced Thrombocytopenia and Thrombosis
Which keywords describe Samuel Zachary Goldhaber's research?
The keywords of their largest research topics: Antithrombotic Therapy, Risk Factors, Clinical Practice Guidelines, Diagnosis, Pulmonary Embolism, Venous Thromboembolism, Guidelines and Anticoagulant Therapy.
- Heparin-Induced Thrombocytopenia
- Catheter-Related Infections
- Chronic Venous Insufficiency
- Ischemic Stroke
- Protease-Activated Receptors
- Acute Coronary Syndromes
- Anticoagulant Therapy
- Venous Thromboembolism
- Diagnosis
- Risk Factors
- Antithrombotic Therapy
- Clinical Practice Guidelines
- Pulmonary Embolism
- Guidelines
- Atrial Fibrillation
- Myocardial Infarction
- Thrombin
- Thrombolysis
- Varicose Veins
- Central Venous Catheterization
- Thrombosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Antithrombotic Therapy9032 topics
- Risk Factors8912 topics
- Clinical Practice Guidelines8682 topics
- Diagnosis8542 topics
- Pulmonary Embolism7891 topic
- Venous Thromboembolism7891 topic
- Guidelines5252 topics
- Anticoagulant Therapy3911 topic
- Atrial Fibrillation3911 topic
- Acute Coronary Syndromes1341 topic
- Myocardial Infarction1341 topic
- Protease-Activated Receptors1141 topic
- Thrombin1141 topic
- Ischemic Stroke1021 topic
- Thrombolysis1021 topic
- Chronic Venous Insufficiency791 topic
- Varicose Veins791 topic
- Catheter-Related Infections781 topic
- Central Venous Catheterization781 topic
- Heparin-Induced Thrombocytopenia651 topic
- Thrombosis651 topic
Where does Samuel Zachary Goldhaber work?
Samuel Zachary Goldhaber's main affiliation in the publication record is Brigham and Women's Hospital, United States.
How many publications and citations does Samuel Zachary Goldhaber have?
OpenAlex counts 1,085 works and 94,034 citations for Samuel Zachary Goldhaber, an h-index of 136, ranking #43,713 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Samuel Zachary Goldhaber. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.